AGI.do

Products

What will AGI do for Artenimol?

This classification denotes an antimalarial agent with the molecular formula C15H24O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6A9O50735X, chemically known as (3r,5as,6r,8as,9r,10s,12r,12ar)-decahydro-3,6,9-trimethyl-3,12-epoxy-12h-pyrano(4,3,-j)-1,2-benzodioxepin-10-ol but generally known as artenimol, which bears US NIH Compound Identifier 179336. European Medicines Agency schedules Artenimol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB30709. The term ARTENIMOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, No. 1, 2000, List 43). World Health Organization schedules artenimol in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule artenimol under HS 29329985 and SITC 51569. As of Q4 2014, ARTENIMOL remains the US FDA Preferred Term for this commodity. Artenimol bears US NLM identifiers UMLS ID C0058108 and NCI Concept Code C87432. SMILES: O1OC2(OC3OC(O)C(C4C13C(C(CC4)C)CC2)C)C.

How AGI delivers it

Four ways AGI delivers for Artenimol

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Artenimol, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Artenimol, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Artenimol connects

measured by

  • Alpha-Beta Anomer Ratiomodel
  • Assay Puritymodel
  • Chromatographic Impurity Profilemodel
  • Optical Rotationmodel
  • Residual Solventmodel

Go deeper

Explore Artenimol

Read the deeper take on agi.asView as markdown